Most cancers are classified into five stages, numbered 0 through IV (4). The higher the number, the more the cancer has grown or spread. Stage 0 means abnormal cells are present but haven’t invaded nearby tissue, while Stage IV means the cancer has spread to distant parts of the body. This numbering system applies to most solid tumors, though some cancers use entirely different frameworks.
What Each Stage Means
Stage 0: Often called “carcinoma in situ,” this is the earliest possible classification. Abnormal cells exist in one location but haven’t grown into surrounding tissue. Many Stage 0 findings are highly treatable and some physicians don’t consider them true cancer yet.
Stage I: Cancer is small and only in the area where it started. It hasn’t spread to lymph nodes or other organs. This is sometimes referred to as early-stage cancer.
Stage II and Stage III: These indicate larger tumors or cancer that has grown into nearby structures. Stage III typically means cancer has reached nearby lymph nodes. The exact criteria vary by cancer type, so a Stage II breast cancer and a Stage II colon cancer don’t look alike in terms of tumor size or specific characteristics.
Stage IV: Cancer has spread (metastasized) to distant organs or tissues far from the original tumor. This is the most advanced stage and is sometimes called metastatic cancer regardless of where the original tumor started.
Stages II and III are often subdivided further using letters. You might hear Stage IIIA or Stage IIB, for example, which provide more granular detail about how far the cancer has progressed within that stage.
How the TNM System Works
Behind those Roman numerals is a more detailed classification called the TNM system, maintained by the American Joint Committee on Cancer (AJCC). Three factors determine your overall stage number:
- T (Tumor): The size and extent of the primary tumor, rated T1 through T4. Higher numbers mean a larger tumor or more growth into nearby tissues.
- N (Nodes): Whether cancer has reached nearby lymph nodes, rated N0 (no lymph node involvement) through N3 (cancer in many nearby lymph nodes).
- M (Metastasis): Whether cancer has spread to distant parts of the body. M0 means it hasn’t; M1 means it has.
A specific combination of T, N, and M values maps to an overall stage. For instance, a small tumor (T1) with no lymph node involvement (N0) and no distant spread (M0) would typically be Stage I. A tumor of any size with distant metastasis (M1) is Stage IV regardless of the T or N values. The AJCC recently shifted from publishing a single staging manual to a rolling update system called Version 9, where individual cancer types get updated on their own timeline rather than all at once.
Clinical Staging vs. Pathological Staging
You may receive a stage at two different points. Clinical staging happens first, based on physical exams, imaging scans, and biopsies before any surgery. Pathological staging comes after surgery, when a pathologist examines the removed tumor and any lymph nodes under a microscope. Pathological staging is generally more precise because the tissue is analyzed directly rather than estimated through scans.
If cancer returns after treatment, doctors may restage it. Restaging uses the same tools (scans, exams, sometimes new biopsies) to assess how much cancer is present and where it has spread. A restaged cancer can look very different from the original diagnosis.
Cancers That Use Different Systems
Not every cancer fits neatly into the 0-through-IV framework. Blood cancers like leukemia don’t form solid tumors, so the TNM system doesn’t apply. Chronic lymphocytic leukemia, for instance, uses the Rai staging system in North America, which evaluates five specific factors: abnormal white blood cell counts, enlarged lymph nodes, enlarged organs, low red blood cell counts, and low platelet counts. Lymphomas use a separate framework called the Lugano classification, which evolved from an older system called Ann Arbor staging.
Brain and spinal cord tumors also follow their own path. The World Health Organization grades these tumors on a scale that reflects how abnormal the cells look and how aggressively they’re likely to grow. These WHO grades inform treatment decisions and outlook but aren’t the same as the standard stage numbers used for other solid tumors. The AJCC added updated brain and spinal cord staging protocols in 2023, but the WHO grading system remains central to how these tumors are classified in practice.
Why Staging Matters for Treatment
Your stage shapes nearly every treatment decision that follows. Early-stage cancers (Stages 0 through II) are more likely to be treated with surgery alone or surgery plus a short course of additional therapy. Later stages often require combinations of treatment that may include systemic therapies designed to reach cancer cells throughout the body.
Stage also provides a general picture of prognosis, though it’s far from the only factor. Two people with the same stage of the same cancer can have very different outcomes depending on the tumor’s specific biology, their overall health, and how the cancer responds to treatment. Modern staging increasingly incorporates molecular markers and genetic features of the tumor alongside the traditional size-and-spread measurements, making the picture more detailed than the stage number alone might suggest.
The stage assigned at diagnosis typically stays in your medical record permanently, even if the cancer shrinks or disappears with treatment. If someone is diagnosed at Stage III and later has no detectable cancer, they’re described as Stage III in remission, not reclassified to a lower stage. This convention helps doctors track outcomes and compare treatments across patients over time.